Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

European guideline and expert statements on the management of narcolepsy in adults and children

Research output: Contribution to journalReviewResearchpeer-review

DOI

  1. B-waves are present in patients without intracranial pressure disturbances

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: Results from a randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Nocturnal eye movements in patients with idiopathic rapid eye movement sleep behaviour disorder and patients with Parkinson's disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Morbidity in patients with NREM parasomnias in the Danish population

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  5. Mortality in patients with NREM parasomnias in the Danish population

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  • Claudio L A Bassetti
  • Ulf Kallweit
  • Luca Vignatelli
  • Giuseppe Plazzi
  • Michel Lecendreux
  • Elisa Baldin
  • Leja Dolenc-Groselj
  • Poul Jennum
  • Ramin Khatami
  • Mauro Manconi
  • Geert Mayer
  • Markku Partinen
  • Thomas Pollmächer
  • Paul Reading
  • Joan Santamaria
  • Karel Sonka
  • Yves Dauvilliers
  • Gert J Lammers
View graph of relations

BACKGROUND AND PURPOSE: Narcolepsy is an uncommon hypothalamic disorder of presumed autoimmune origin that usually requires lifelong treatment. This paper aims to provide evidence-based guidelines for the management of narcolepsy in both adults and children.

METHODS: The European Academy of Neurology (EAN), European Sleep Research Society (ESRS), and European Narcolepsy Network (EU-NN) nominated a task force of 18 narcolepsy specialists. According to the EAN recommendations, 10 relevant clinical questions were formulated in PICO format. Following a systematic review of the literature (performed in Fall 2018 and updated in July 2020) recommendations were developed according to the GRADE approach.

RESULTS: A total of 10,247 references were evaluated, 308 studies were assessed and 155 finally included. The main recommendations can be summarized as follows: (i) excessive daytime sleepiness (EDS) in adults-scheduled naps, modafinil, pitolisant, sodium oxybate (SXB), solriamfetol (all strong); methylphenidate, amphetamine derivatives (both weak); (ii) cataplexy in adults-SXB, venlafaxine, clomipramine (all strong) and pitolisant (weak); (iii) EDS in children-scheduled naps, SXB (both strong), modafinil, methylphenidate, pitolisant, amphetamine derivatives (all weak); (iv) cataplexy in children-SXB (strong), antidepressants (weak). Treatment choices should be tailored to each patient's symptoms, comorbidities, tolerance and risk of potential drug interactions.

CONCLUSION: The management of narcolepsy involves non-pharmacological and pharmacological approaches with an increasing number of symptomatic treatment options for adults and children that have been studied in some detail.

Original languageEnglish
Article numbere13387
JournalJournal of Sleep Research
Volume30
Issue number6
Pages (from-to)e13387
ISSN1365-2869
DOIs
Publication statusPublished - Dec 2021

Bibliographical note

© 2021 The Authors. Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Academy of Neurology and European Sleep Research Society.

    Research areas

  • Adult, Cataplexy, Child, Humans, Modafinil/therapeutic use, Narcolepsy/diagnosis, Sleep, Sodium Oxybate/therapeutic use, cataplexy, narcolepsy, European, management, guideline

ID: 72158195